Rize Oncology Inc (RIZE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 43 | 153 | 212 | 383 | 400 |
| Operating Income | -43 | -153 | -212 | -383 | -400 |
| Other Income | 16 | 13 | 7 | 5 | -1 |
| Pre-tax Income | -28 | -140 | -204 | -377 | -401 |
| Net Income Continuous | -28 | -140 | -204 | -377 | -401 |
| Net Income | $-28 | $-140 | $-204 | $-377 | $-401 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| EBITDA(a) | $-43 | $-153 | $-212 | $-377 | $-401 |